WYETH PAYS USD490 MILLION TO RESOLVE CRIMINAL AND CIVIL LIABILITIES OVER IMMUNOSUPPRESIVE DRUG
August 1st, 2013
PFIZER-owned Wyeth Pharmaceuticals Inc has agreed to pay USD490.9 million to resolve criminal and civil liability claims from its unlawful marketing of the prescription immunosuppressant drug Rapamune, the USA’s justice department has announced. It claims that Wyeth marketed the medicine in America for uses beyond those approved by the US Food and Drug Administration (FDA). These were preventing kidney transplant patients rejecting their new organs. However, the justice department cited claims that Wyeth trained its national Rapamune sales staff to promote ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.